CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rochester Medical Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rochester Medical Corporation
One Rochester Medical Drive
Phone: (507) 533-9600p:507 533-9600 Stewartville, MN  55976-1647  United States Fax: (507) 533-9725f:507 533-9725
This company ceased filing statements with the SEC on 11/25/2013.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Rochester Medical Corporation develops, manufactures and markets a range of polyvinyl chloride (PVC)-free and latex-free urinary continence and urine drainage care products for the extended care and acute care markets. The Company’s extended care products include a range of male external catheters (MECs) for managing male urinary incontinence and a range of intermittent catheters for managing both male and female urinary retention. Along with its silicone male external catheters, it also sells a range of latex male external catheters in the United Kingdom. Its Magic3 is a range of silicone intermittent catheters. Its extended care products also include the FemSoft Insert, a soft, liquid-filled, conformable urethral insert for managing female stress urinary incontinence in adult females. Effective November 14, 2013, CR Bard Inc acquired the entire share capital of Rochester Medical Corp.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20139/30/2012YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Anthony J.Conway 68 11/1/2008 5/1/1988
Chief Financial Officer, Treasurer, Secretary, Director David A.Jonas 48 11/20/2008 11/1/2000
Vice President - U.S. Sales and Marketing James M.Carper 61 1/1/2011 11/20/2008
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Laprolan B.V.
Rochester Medical Ltd.
ROCM

General Information
Stock Exchange: NASD
Federal Tax Id: 411613227
Fax Number: (507) 533-9725


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023